Leading Cancer Researcher: They’re Ignoring My Research, Cancer Patients Must Know This!
In a Nutshell
Cancer arises from damaged mitochondria that force cells to rely on inefficient glucose and glutamine fermentation instead of oxygen-based energy production. The glucose-ketone index (GKI) provides a measurable target to shift metabolism into a "prevention zone" that starves tumors while protecting healthy cells. Metabolic therapy—nutritional ketosis plus repurposed drugs like mebendazole—can be combined with lower-dose conventional treatments to extend survival, as shown in long-term glioblastoma cases.
These notes were generated by AI and may contain inaccuracies.
A paper is under embargo that is expected to be a lead article in Frontiers in Science. It outlines a strategy to manage cancer effectively and keep patients alive significantly longer, providing hope to the hopeless.
All chronic diseases and cancer result from damage to mitochondria. The field of cancer research has yet to accept this mitochondrial origin of cancer. There are 1,700 people dying from cancer daily in the United States, which equals 70 per hour, and the numbers continue to worsen each year.
Modern environments damage mitochondria through massive amounts of highly processed carbohydrates, inactivity, emotional stress, and poor sleep habits. The domestic dog serves as an example: cancer is the number one killer of domestic dogs, while wolves in the wild rarely develop cancer. Wolves run freely and eat natural foods, whereas dogs often live in apartments with limited exercise and become obese and develop cancer.
Professor Thomas Seyfried has committed his life to managing cancer effectively without toxicity, based on scientific work in the field. His perspective differs from mainstream oncology and is grounded in the science of Otto Warburg from the 1920s, 1930s, and 1940s. Warburg demonstrated that cancer is fundamentally a mitochondrial metabolic disease.
Sign in to read the full notes
Get access to AI-generated notes, topic timestamps, and more.